Diabetes, obesity, hypertension and risk of severe COVID-19: a protocol for systematic review and meta-analysis.

ABSTRACT:

Introduction

Previous evidence from several countries, including China, Italy, Mexico, UK and the USA, indicates that among patients with confirmed COVID-19 who were hospitalised, diabetes, obesity and hypertension might be important risk factors for severe clinical outcomes. Several preliminary systematic reviews and meta-analyses have been conducted on one or more of these non-communicable diseases, but the findings have not been definitive, and recent evidence has become available from many more populations. Thus, we aim to conduct a systematic review and meta-analysis of observational studies to assess the relationship of diabetes, obesity and hypertension with severe clinical outcomes in patients with COVID-19.

Method and analysis

We will search 16 major databases (MEDL

SUBMITTER: Li C 

PROVIDER: S-EPMC8628113 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature